Fri, Aug 22, 2014, 10:47 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Genzyme Molecular Oncol. (GZMO) Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • gladpick gladpick Apr 26, 2002 10:13 PM Flag

    Henri Termeer's bonus

    Yep. Unfortunately stock analysts are not interested in tracking stocks and therefore there is nobody to publicize this company. (Only one analyst follows this stock.) Henry Termeer of the parent company could care less about GZMO. All he is interested in is to use GZMO's losses to reduce Genzyme's taxes and thus increase its profitability. The relationship is both a curse and a blessing. A curse because the market does not follow and/or value a tracking stock for its full potential. On the other hand it is a blessing because it can rely on the parent company for financing rather than turning to the market to raise money at these low prices.
    Hopefully in the long run, GZMO can produce a product to prove that it can stand on its own feet. So far all we have heard from Gail Mederis is a lot of noise. Hopefully one of these days she can produce a viable product. This stock is for long term patient investors who can wait for a while until it can produce a viable product and thus be recognized on its own merits rather than a step child of Genzyme.


Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Keurig Green Mountain, Inc.
NasdaqGSFri, Aug 22, 2014 4:00 PM EDT, Inc
NYSEFri, Aug 22, 2014 4:00 PM EDT